Effect of Litramine on Fat Excretion

Inclusion criteria

• BMI 20-30 kg/m2
• Accustomed to 3 main meals/day
• Commitment to avoid the use of other weight management products during study
• Females' agreement to use appropriate birth control methods during the active study period
• Self-reported regular bowel movement (1-2 times per day)
• Subject declares in writing his/her consent to participate, understands requirements of the study and is willing to comply

Exclusion criteria

• Known sensitivity to the ingredients of the device
• Diabetes mellitus (type 1 or 2)
• History or clinical signs of endocrine disorders
• Clinically relevant excursions of safety parameter
• Current use of anti-depressants
• Presence of acute or chronic gastrointestinal disease
• Uncontrolled hypertension (more than 160/110 mm Hg)
• Stenosis in the gastrointestinal tract
• Bariatric surgery
• Abdominal surgery within the last 6 months prior to enrollment
• History of eating disorders such as bulimia, anorexia nervosa within the past 12 months
• Other serious organ or systemic diseases such as cancer
• Any medication that could influence gastrointestinal functions
• Pregnancy or nursing
• Any medication or use of products for the treatment of obesity within 6 weeks prior to enrolment
• History of abuse of drugs, alcohol or medication
• Presence of other factor(s) that, in the investigator's judgment, should preclude subject participation